Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
CD20 as a gatekeeper of the resting state of human B cells | PNAS
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
Espressione di CD20 sui linfociti B nel midollo osseo ed in periferia.... | Download Scientific Diagram
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
SciELO - Brasil - CD20 role in pathophysiology of Hodgkin's disease CD20 role in pathophysiology of Hodgkin's disease
CD20 - Wikipedia
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
CD20 CD3 Cancer Immunity Targets | Genentech Oncology
CD-20 | ドライブレコーダー | セルスター工業株式会社
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives - Kidney International
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab | Nature Communications
CD20 as a gatekeeper of the resting state of human B cells | PNAS
CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies | Bentham Science
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
CD antigens expression in B cells
